Good evening :)
Place Order
Add to Watchlist

Strides Pharma Science Ltd

STAR

Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,264 cr, stock is ranked 665
High RiskStock is 3.11x as volatile as Nifty
645.205.08% (-34.50)
645.205.08% (-34.50)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,264 cr, stock is ranked 665
High RiskStock is 3.11x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,264 cr, stock is ranked 665
High RiskStock is 3.11x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
25.243.020.37%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
48.596.210.55%

Forecast & Ratings

Detailed Forecast 
67%
Analysts have suggested that investors can buy this stock

from 3 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

PE Ratio
43.75
1Y Return
11.85%
Buy Reco %
85.29
PE Ratio
28.85
1Y Return
2.39%
Buy Reco %
72.73
PE Ratio
62.82
1Y Return
15.73%
Buy Reco %
70.37
PE Ratio
53.95
1Y Return
8.82%
Buy Reco %
80.00
PE Ratio
18.28
1Y Return
4.36%
Buy Reco %
43.75
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 10.24%, vs industry avg of 9.04%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 1.16% to 1.1%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue2,961.593,097.803,534.852,545.662,909.443,518.843,259.233,935.354,145.604,526.37
Raw Materialssubtract1,612.381,432.251,286.651,189.201,167.291,686.501,407.041,629.551,624.563,729.66
Power & Fuel Costsubtract77.1833.8751.3354.3964.4964.5871.5485.8286.48
Employee Costsubtract357.70419.16434.05329.44442.56550.15646.91732.02751.13
Selling & Administrative Expensessubtract323.35339.47409.34276.20338.51473.78577.98526.31477.75
Operating & Other expensessubtract154.1154.45313.14196.74525.2598.10798.52724.88733.28
Depreciation/Amortizationsubtract131.25126.15154.04117.39173.70206.29233.01243.25220.68195.22
Interest & Other Itemssubtract168.17183.10196.2479.29155.72150.07176.74261.14314.45286.55
Taxes & Other Itemssubtract28.92109.6025.55-21.605.5320.94-192.30-65.007.8966.76
EPS6.1818.9731.5015.631.7813.12-22.47-9.86-3.4011.83
DPS2.121.910.851.316.131.100.000.661.101.09
Payout ratio0.340.100.030.083.450.080.00——0.09

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Strides Pharma Science Ltd-88.703.020.37%
Sun Pharmaceutical Industries Ltd43.756.240.77%
Cipla Ltd28.854.440.88%
Torrent Pharmaceuticals Ltd62.8215.180.91%

Price Comparison

Compare STAR with any stock or ETF
Compare STAR with any stock or ETF
STAR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 2.12%

Decreased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.60%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding26.82%10.86%6.06%28.48%27.77%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Shareholding History

SepDec '23MarJunSepDec '2417.25%19.45%24.57%26.71%30.08%28.48%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Strides Pharma Science Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
3.6560%0.91%-1.10%34/98 (-21)
1.5561%0.99%-1.20%20/67 (-6)
0.8454%0.55%-0.06%163/203 (-3)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 9, 2024

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Sep 9, 2024

Cash Dividend

Ex DateEx DateAug 4, 2023

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateAug 5, 2021

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Aug 5, 2021

Cash Dividend

Ex DateEx DateJul 24, 2020

Final
Final | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Jul 24, 2020

Cash Dividend

Ex DateEx DateAug 22, 2019

Interim
Interim | Div/Share: ₹12.00

Dividend/Share

₹12.00

Ex DateEx Date

Aug 22, 2019

News & Opinions
Corporate
Strides Pharma Science announces change in directorate

Strides Pharma Science announced the change in designation of Arun Kumar (DIN: 00084845) from Executive Chairperson to Non-Executive Chairperson of the Company effective 05 April 2025. Arun Kumar, Founder and Executive Chairperson of the Company, has served in various positions on the Board of Strides since its inception. His current appointment as Executive Director is expiring on 06 April 2025. Upon successful transition of executive responsibilities to Badree Komandur (who was appointed as Managing Director and Group CEO effective 01 June 2024) and the Leadership team at Strides, Arun has opted to assume the role of Non-Executive Chairperson effective 05 April 2025.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Strides Pharma Science appoints director

Strides Pharma Science has appointed Mukta Arora (DIN: 07225715) as Independent Director of the Company effective 01 February 2025. Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Strides Pharma Science consolidated net profit rises 77.07% in the December 2024 quarter

Net profit of Strides Pharma Science rose 77.07% to Rs 87.95 crore in the quarter ended December 2024 as against Rs 49.67 crore during the previous quarter ended December 2023. Sales rose 14.71% to Rs 1153.67 crore in the quarter ended December 2024 as against Rs 1005.77 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1153.671005.77 15 OPM %18.2312.87 - PBDT164.7068.49 140 PBT116.2819.04 511 NP87.9549.67 77 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Strides Pharma Science to hold board meeting

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 30 January 2025.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Spotlight
Strides Pharma jumps after OneSource set to debut on Jan 24

OneSource Specialty Pharma (OneSource) is India's first specialty pharma Contract Development and Manufacturing Organization (CDMO). OneSource shall start trading on NSE and BSE from Friday, January 24, 2025 onwards, stated the company. Strides Pharma Science is engaged in developing and manufacturing a wide range of IP-led niche pharmaceutical products. It reported a consolidated net profit of Rs 93.23 crore in Q1 FY25 as against a net loss of Rs 131.34 crore posted in Q2 FY24. Revenue from operations grew 20.17% to Rs 1201.1 crore in the quarter ended September 2024. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Spotlight
Strides Pharma Science Ltd leads gainers in 'A' group

Authum Investment & Infrastructure Ltd, Century Plyboards (India) Ltd, Tanla Platforms Ltd and Amber Enterprises India Ltd are among the other gainers in the BSE's 'A' group today, 01 January 2025.Strides Pharma Science Ltd surged 10.27% to Rs 727.55 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 1.32 lakh shares were traded on the counter so far as against the average daily volumes of 78858 shares in the past one month. Authum Investment & Infrastructure Ltd spiked 9.59% to Rs 1867.15. The stock was the second biggest gainer in 'A' group. On the BSE, 6551 shares were traded on the counter so far as against the average daily volumes of 8287 shares in the past one month. Century Plyboards (India) Ltd soared 9.46% to Rs 808. The stock was the third biggest gainer in 'A' group. On the BSE, 67435 shares were traded on the counter so far as against the average daily volumes of 8175 shares in the past one month. Tanla Platforms Ltd exploded 9.29% to Rs 734.45. The stock was the fourth biggest gainer in 'A' group. On the BSE, 68543 shares were traded on the counter so far as against the average daily volumes of 46356 shares in the past one month. Amber Enterprises India Ltd added 6.08% to Rs 7844. The stock was the fifth biggest gainer in 'A' group. On the BSE, 24875 shares were traded on the counter so far as against the average daily volumes of 40408 shares in the past one month. Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Strides Pharma Science Ltd leads losers in 'A' group

CARE Ratings Ltd, Avalon Technologies Ltd, Adani Green Energy Ltd and Easy Trip Planners Ltd are among the other losers in the BSE's 'A' group today, 04 December 2024.Strides Pharma Science Ltd lost 5.11% to Rs 1513.1 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 34509 shares were traded on the counter so far as against the average daily volumes of 30958 shares in the past one month.CARE Ratings Ltd crashed 4.56% to Rs 1430. The stock was the second biggest loser in 'A' group.On the BSE, 4186 shares were traded on the counter so far as against the average daily volumes of 11904 shares in the past one month.Avalon Technologies Ltd tumbled 4.55% to Rs 875. The stock was the third biggest loser in 'A' group.On the BSE, 53104 shares were traded on the counter so far as against the average daily volumes of 1.01 lakh shares in the past one month.Adani Green Energy Ltd dropped 3.66% to Rs 1264.35. The stock was the fourth biggest loser in 'A' group.On the BSE, 2.38 lakh shares were traded on the counter so far as against the average daily volumes of 6.83 lakh shares in the past one month.Easy Trip Planners Ltd corrected 3.53% to Rs 16.38. The stock was the fifth biggest loser in 'A' group.On the BSE, 52.31 lakh shares were traded on the counter so far as against the average daily volumes of 23.43 lakh shares in the past one month.Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Strides Pharma Science allots 2.04 lakh equity shares under ESOP

Strides Pharma Science has allotted 2,04,500 equity shares under ESOP. Consequent to above, the paid-up share capital of the Company has increased from Rs. 91,95,82,140 consisting of 9,19,58,214 equity shares of Rs. 10/- each to 92,16,27,140 consisting of 9,21,62,714 equity shares of Rs. 10/- each. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Strides Pharma Science fixes record date for scheme of arrangement

Strides Pharma Science has fixed 06 December 2024 as record date for r determining names of the equity shareholders of Strides who shall be entitled for allotment of equity shares by OneSource, as consideration under the scheme of arrangement. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
OneSource Specialty Pharma successfully raises Rs 801 cr via equity issuance

Strides Pharma Science announced that its associate company, OneSource Specialty Pharma has successfully completed the fundraise activity and has allotted equity shares to the marquee domestic and international investors who participated in this issue. OneSource Specialty Pharma has allotted 6,277,909 fully paid up equity shares at a price of Rs 1,276/- (including a premium of Rs 1,275/-) per share on a private placement basis to marquee domestic and international investors. The total consideration received from the allotment stands at Rs 801 crore, valuing OneSource at a pre-money equity valuation of USD 1.65 billion. This milestone reinforces OneSource's strong positioning as India's first specialty pharma CDMO and its readiness for robust growth ahead of its proposed listing. Powered by Capital Market - Live

2 months agoCapital Market - Live